Pictured: Structural formula of IBNtxA
In the Lab
By Eva Kiesler, PhD, Science Writer/Editor  |  Tuesday, December 13, 2011

Scientists have generated a compound that could potentially be used to create a new type of pain medication that may prevent the side effects of currently available painkillers.

In the Lab
By Julie Grisham, MS, Science Writer/Editor  |  Monday, December 12, 2011

A Memorial Sloan Kettering study suggests that a new, experimental treatment could make bone marrow and stem cell transplantation safer and more effective.

Pictured: Clifford Hudis
Honor
By Memorial Sloan Kettering  |  Wednesday, December 7, 2011

Memorial Sloan Kettering medical oncologist Clifford A. Hudis has been elected President of the American Society of Clinical Oncology, the world’s leading professional organization representing more than 30,000 physicians who care for people with cancer.

Pictured: Mark Kris & Ann Culkin
Honor
By Memorial Sloan Kettering  |  Monday, December 5, 2011

Congratulations to Mark Kris, Chief of the Thoracic Oncology Service, and Ann Culkin, nurse on the Thoracic Oncology Service, for receiving the Wholeness of Life Award 2011 from the HealthCare Chaplaincy.

Pictured: Lloyd J. Old
In Memoriam
By Memorial Sloan Kettering  |  Sunday, December 4, 2011

Memorial Sloan Kettering notes with sadness the death of Lloyd J. Old, who was internationally recognized as one of the founders and standard bearers of the field of tumor immunology.

Research
Pictured: Breast tumor treated with paclitaxel
In the Lab
By Eva Kiesler, PhD, Science Writer/Editor  |  Friday, December 2, 2011

Recent findings by Memorial Sloan Kettering investigators suggest it might be possible to improve the effectiveness of chemotherapy for breast cancer by combining the treatment with a new type of drug called a cathepsin inhibitor.

Social Media
By Allyson Collins, MS, Science Writer/Editor  |  Tuesday, November 29, 2011

This holiday season, we encourage Facebook fans to interact with us through our new Giving tab! You can make a donation, post a support or survivor badge on your wall for your friends to see, sign up to receive our supporter e-newsletter, learn about ways to get involved, and read stories featuring community fundraising events.

Facebook; Giving
Pictured: David Solit
In the Lab
By Media Staff  |  Wednesday, November 23, 2011

Research led by investigators at Memorial Sloan Kettering has identified a previously unknown mechanism of resistance to the newly approved melanoma drug vemurafenib.

In the News
By Media Staff  |  Wednesday, November 23, 2011

Chief of Thoracic Oncology Mark Kris offers his perspective on a promising new tactic for treating lung and other cancers in this story from CBS Evening News with Scott Pelley. The strategy tailors cancer treatment to each individual patient.

Pictured: Monica Morrow
In the Clinic
By Jim Stallard, MA, Writer/Editor  |  Monday, November 21, 2011

Research published in the November 19 issue of The Lancet finds that MRI use for breast cancer screening in women at high risk for the disease – due to family history or a genetic mutation – detects more cancers than screening mammography.

In the Clinic
By Esther Napolitano, BS, Science Writer/Editor  |  Thursday, November 17, 2011

A new study has found that the overall colonoscopy screening rate has improved by 20 percent in five years among underserved and uninsured New Yorkers aged 50 years and older.

Pictured: Evelyn Lauder
In Memoriam
By Memorial Sloan Kettering  |  Monday, November 14, 2011

Memorial Sloan Kettering mourns the loss of Evelyn H. Lauder, who was a tireless cancer research advocate and a member of our Board of Overseers.

Center News

Stay Informed

Get the latest information about cancer care and research every month.